On February 9, 2024, Bio-Rad Laboratories, Inc.?s board of directors appointed Norman Schwartz, the Company?s President and Chief Executive Officer and the Chairman of the Board, as the Company?s principal financial officer until a permanent replacement for Ilan Daskal has been appointed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
293.8 USD | -0.64% | +4.20% | -8.99% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.99% | 8.31B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Bio-Rad Laboratories, Inc. Appoints Norman Schwartz as Principal Financial Officer